Compound information
- Natural Products
- ZC132954
- Molecular Formula
- C13H15FN2O3S
- Molecular Weight
- 298.07874156 g/mol
- Structure
-
- IUPAC Name
- 1-[4-(4-fluorophenyl)sulfonylpiperazin-1-yl]prop-2-en-1-one
- InChI
- InChI=1S/C13H15FN2O3S/c1-2-13(17)15-7-9-16(10-8-15)20(18,19)12-5-3-11(14)4-6-12/h2-6H,1,7-10H2
- InChI Key
- NRKVZNKMYYAVJB-UHFFFAOYSA-N
- SMILES
- C=CC(=O)N1CCN(S(=O)(=O)c2ccc(F)cc2)CC1
- Source
- ZINC001353214472
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 20 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 57.69 Å2 | LogP | 0.979 |
LogS | -2.348 | LogD | 1.624 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.028 | Pgp substrate | 0.03 |
HIA | 0.961 | F20 % | 0.993 |
F30 % | 0.876 | Caco-2 | -4.408 |
MDCK | -4.904 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.747 | PPB | 89.633 |
VD | 0.601 | Fu | 1.163 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.488 |
CYP2A6 substrate | 0.509 | CYP2B6 substrate | 0.598 |
CYP2C19 inhibitor | 0.432 | CYP2C19 substrate | 0.767 |
CYP2C8 substrate | 0.724 | CYP2C9 inhibitor | 0.11 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.009 |
CYP2D6 substrate | 0.882 | CYP2E1 substrate | 0.824 |
CYP3A4 inhibitor | 0.017 | CYP3A4 substrate | 0.986 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.13 | CL | 6.208 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.26 | Hepatotoxicity | 0.99 |
Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.579 |
FDAMDD | 0.559 | Skin Sensitization | 0.12 |
Carcinogenicity | 0.82 | Eye Corrosion | 0.497 |
Eye Irritation | 0.828 | Respiratory Toxicity | 0.091 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.742 | IGC50 | 3.245 |
LC50FM | -0.828 | LC50DM | 4.631 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.121 | NR-AR-LBD | 0.462 |
NR-AhR | 0.014 | NR-Aromatase | 0.045 |
NR-ER | 0.259 | NR-ER-LBD | 0.45 |
NR-PPAR-gamma | 0.517 | SR-ARE | 0.898 |
SR-ATAD5 | 0.417 | SR-HSE | 0.093 |
SR-MMP | 0.019 | SR-p53 | 0.038 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.